Summary
Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.
The global Argatroban market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Argatroban Powder
Argatroban Injection
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Pfizer
SANDOZ
GlaxoSmithKline
fresenius-kabi
Eagle Pharmaceuticals
Mitsubishi Tanabe Pharma
Teva Pharmaceutical Industries
WEST-WARD
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Heparin-induced thrombocytopenia (HIT)
Percutaneous Coronary Intervention
Cerebral arterial thrombosis
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Table of Contents 1 Market Overview 1.1 Objectives of Research Figure Argatroban Picture Table Product Specifications of Argatroban Table Products Segment of Argatroban Table Global Argatroban Market by Type, 2011-2022 (USD Million) 1.2.1.1 Argatroban Powder Table Argatroban Powder Overview 1.2.1.2 Argatroban Injection Table Argatroban Injection Overview Table Application Segment of Argatroban Table Global Argatroban Market by Application, 2011-2022 (USD Million) 1.2.2.1 Heparin-induced thrombocytopenia (HIT) Table Heparin-induced thrombocytopenia (HIT) Overview 1.2.2.2 Percutaneous Coronary Intervention Table Percutaneous Coronary Intervention Overview 1.2.2.3 Cerebral arterial thrombosis Table Cerebral arterial thrombosis Overview Table Global Argatroban Market by Region, 2011-2022 (USD Million) 2 Industry Chain 2.1 Industry Chain Structure Figure Industry Chain Structure of Argatroban Table Cost of Argatroban Figure Manufacturing Process of Argatroban Figure SWOT of Argatroban Table Market Dynamics 3 Environmental Analysis Table Policy of Argatroban Table GDP of Major Countries Table Technology of Argatroban Table Market Entry of Argatroban 4 Market Segmentation by Type 4.1 Market Size4.1.1 Argatroban Powder Market, 2013-2018 Figure Argatroban Powder Market Size and Growth, 2012-2018 (USD Million) Figure Argatroban Powder Market Size and Growth, 2012-2018 (in Volume) Table Argatroban Powder CAGR by Revenue and Volume, 2012-2018 4.1.2 Argatroban Injection Market, 2013-2018 Figure Argatroban Injection Market Size and Growth, 2012-2018 (USD Million) Figure Argatroban Injection Market Size and Growth, 2012-2018 (in Volume) Table Argatroban Injection CAGR by Revenue and Volume, 2012-2018 4.2 Market Forecast4.2.1 Argatroban Powder Market Forecast, 2020-2025 Figure Argatroban Powder Market Estimates and Forecasts, 2020-2025 (USD Million) Figure Argatroban Powder Market Estimates and Forecasts, 2020-2025 (in Volume) Table Argatroban Powder CAGR by Revenue and Volume, 2012-2024 4.2.2 Argatroban Injection Market Forecast, 2020-2025 Figure Argatroban Injection Market Estimates and Forecasts, 2020-2025 (USD Million) Figure Argatroban Injection Market Estimates and Forecasts, 2020-2025 (in Volume) Table Argatroban Injection CAGR by Revenue and Volume, 2012-2024 5 Market Segmentation by Application 5.1 Market Size5.1.1 Heparin-induced thrombocytopenia (HIT) Market, 2013-2018 Figure Heparin-induced thrombocytopenia (HIT) Market Size and Growth, 2012-2018 (USD Million) Figure Market Size and Growth, 2012-2018 (in Volume) Table Heparin-induced thrombocytopenia (HIT) CAGR by Revenue and Volume, 2012-2018 5.1.2 Percutaneous Coronary Intervention Market, 2013-2018 Figure Percutaneous Coronary Intervention Market Size and Growth, 2012-2018 (USD Million) Figure Market Size and Growth, 2012-2018 (in Volume) Table Percutaneous Coronary Intervention CAGR by Revenue and Volume, 2012-2018 5.1.3 Cerebral arterial thrombosis Market, 2013-2018 Figure Cerebral arterial thrombosis Market Size and Growth, 2012-2018 (USD Million) Figure Market Size and Growth, 2012-2018 (in Volume) Table Cerebral arterial thrombosis CAGR by Revenue and Volume, 2012-2018 5.2 Market Forecast5.2.1 Heparin-induced thrombocytopenia (HIT) Market Forecast, 2020-2025 Figure Heparin-induced thrombocytopenia (HIT) Market Estimates and Forecasts, 2020-2025 (USD Million) Figure Heparin-induced thrombocytopenia (HIT) Market Estimates and Forecasts, 2020-2025 (in Volume) Table Heparin-induced thrombocytopenia (HIT) CAGR by Revenue and Volume, 2020-2025 5.2.2 Percutaneous Coronary Intervention Market Forecast, 2020-2025 Figure Percutaneous Coronary Intervention Market Estimates and Forecasts, 2020-2025 (USD Million) Figure Percutaneous Coronary Intervention Market Estimates and Forecasts, 2020-2025 (in Volume) Table Percutaneous Coronary Intervention CAGR by Revenue and Volume, 2020-2025 5.2.3 Cerebral arterial thrombosis Market Forecast, 2020-2025 Figure Cerebral arterial thrombosis Market Estimates and Forecasts, 2020-2025 (USD Million) Figure Cerebral arterial thrombosis Market Estimates and Forecasts, 2020-2025 (in Volume) Table Cerebral arterial thrombosis CAGR by Revenue and Volume, 2020-2025 6 Market Segmentation by Region 6.1 Market Size6.1.1 Asia-Pacific6.1.1.1 Asia-Pacific Market, 2012-2018 Figure Asia-Pacific Market Size and Growth, 2012-2018 (USD Million) Figure Asia-Pacific Market Size and Growth, 2012-2018 (in Volume) Table Asia-Pacific CAGR by Revenue and Volume, 2012-2018 6.1.1.2 Asia-Pacific Market by Type Figure Asia-Pacific Market Size by Type Figure Asia-Pacific Market Share by Type 6.1.1.3 Asia-Pacific Market by Application Figure Asia-Pacific Market Size by Application Figure Asia-Pacific Market Share by Application 6.1.2 North America6.1.2.1 North America Market, 2012-2018 Figure North America Market Size and Growth, 2012-2018 (USD Million) Figure North America Market Size and Growth, 2012-2018 (in Volume) Table North America CAGR by Revenue and Volume, 2012-2018 6.1.2.2 North America Market by Type Figure North America Market Size by Type Figure North America Market Share by Type 6.1.2.3 North America Market by Application Figure North America Market Size by Application Figure North America Market Share by Application 6.1.3 Europe6.1.3.1 Europe Market, 2012-2018 Figure Europe Market Size and Growth, 2012-2018 (USD Million) Figure Europe Market Size and Growth, 2012-2018 (in Volume) Table Europe CAGR by Revenue and Volume, 2012-2018 6.1.3.2 Europe Market by Type Figure Europe Market Size by Type Figure Europe Market Share by Type 6.1.3.3 Europe Market by Application Figure Europe Market Size by Application Figure Europe Market Share by Application 6.1.4 South America6.1.4.1 South America Market, 2012-2018 Figure South America Market Size and Growth, 2012-2018 (USD Million) Figure South America Market Size and Growth, 2012-2018 (in Volume) Table South America CAGR by Revenue and Volume, 2012-2018 6.1.4.2 South America Market by Type Figure South America Market Size by Type Figure South America Market Share by Type 6.1.4.3 South America Market by Application Figure South America Market Size by Application Figure South America Market Share by Application 6.1.5 Middle East & Africa6.1.5.1 Middle East & Africa Market, 2012-2018 Figure Middle East & Africa Market Size and Growth, 2012-2018 (USD Million) Figure Middle East & Africa Market Size and Growth, 2012-2018 (in Volume) Table Middle East & Africa CAGR by Revenue and Volume, 2012-2018 6.1.5.2 Middle East & Africa Market by Type Figure Middle East & Africa Market Size by Type Figure Middle East & Africa Market Share by Type 6.1.5.3 Middle East & Africa Market by Application Figure Middle East & Africa Market Size by Application Figure Middle East & Africa Market Share by Application 6.2 Market Forecast6.2.1 Asia-Pacific Market Forecast, 2020-2025 Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (USD Million) Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (in Volume) Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025 6.2.2 North America Market Forecast, 2020-2025 Figure North America Market Estimates and Forecasts, 2020-2025 (USD Million) Figure North America Market Estimates and Forecasts, 2020-2025 (in Volume) Table North America CAGR by Revenue and Volume, 2020-2025 6.2.3 Europe Market Forecast, 2020-2025 Figure Europe Market Estimates and Forecasts, 2020-2025 (USD Million) Figure Europe Market Estimates and Forecasts, 2020-2025 (in Volume) Table Europe CAGR by Revenue and Volume, 2020-2025 6.2.4 South America Market Forecast, 2020-2025 Figure South America Market Estimates and Forecasts, 2020-2025 (USD Million) Figure South America Market Estimates and Forecasts, 2020-2025 (in Volume) Table South America CAGR by Revenue and Volume, 2020-2025 6.2.5 Middle East & Africa Market Forecast, 2020-2025 Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (USD Million) Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (in Volume) Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025 7 Market Competitive 7.1 Global Market by Vendors Table Global Argatroban Market by Vendors, 2012-2018 (in Volume) Table Global Argatroban Market Share by Vendors, 2012-2018 (USD Million) Table Global Argatroban Market Share by Vendors, 2012-2018 (in Volume) Figure Argatroban Market Concentration by Region Table Price Factors List Figure Marketing Channels Overview 8 Major Vendors Table Pfizer Profile List Table Microecological Modulator Operating Data of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table SANDOZ Profile List Table Microecological Modulator Operating Data of SANDOZ (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table GlaxoSmithKline Profile List Table Microecological Modulator Operating Data of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table fresenius-kabi Profile List Table Microecological Modulator Operating Data of fresenius-kabi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 8.5 Eagle Pharmaceuticals Table Eagle Pharmaceuticals Profile List Table Microecological Modulator Operating Data of Eagle Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 8.6 Mitsubishi Tanabe Pharma Table Mitsubishi Tanabe Pharma Profile List Table Microecological Modulator Operating Data of Mitsubishi Tanabe Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 8.7 Teva Pharmaceutical Industries Table Teva Pharmaceutical Industries Profile List Table Microecological Modulator Operating Data of Teva Pharmaceutical Industries (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table WEST-WARD Profile List Table Microecological Modulator Operating Data of WEST-WARD (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 9 Conclusion
Summary: Get latest Market Research Reports on Argatroban. Industry analysis & Market Report on Argatroban is a syndicated market report, published as Global and China Argatroban Market Research by Company, Type & Application 2013-2025. It is complete Research Study and Industry Analysis of Argatroban market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
Last updated on 28 February, 2020